MAPK3 and cancer: Further study will be aimed to explore the exact regulatory mechanism of HER2-AKT/ERK1/2 pathway associated with Nrf2 antioxidant response pathway in HER2-positive cancer cells, which will greatly contribute to develop new therapeutics and therapy strategy against HER2-positive cancers.